Eric Hermes, MD
Assistant Professor, Department of Psychiatry, Yale School of Medicine, New Haven, CT
Dr. Hermes has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
With substance use disorders (SUDs) that are comorbid with chronic insomnia, what would you say are some of the main treatment challenges?
Daniel Carlat, MD
Publisher, The Carlat Addiction Treatment ReportDr. Carlat has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
In this month’s interview with Dr. Eric Hermes, we learned about his approach to treating insomnia in patients with substance use disorders, with a focus on cognitive behavioral therapy. In this article, we’ll look at some non-addictive pharmacological options.
The post-test for this issue is available for one year after the publication date to subscribers only. By successfully completing the test you will be awarded a certificate for 1 CME credit.
Candace Good, MD
Child and adolescent psychiatrist, SunPointe Health, State College, PA
Dr. Good has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
You are evaluating a 16-year-old boy referred for mandated substance use treatment by his high school, where he was found drinking alcohol and smoking cannabis with a friend in the restroom.
Joanna Quigley, MD
Associate medical director for Child and Adolescent Ambulatory Services, University of Michigan, Ann Arbor, MI
Dr. Quigley has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Since they already often seem two steps ahead of us, with adolescents it can be really helpful to use direct routes. Be very specific in your questions. For example, don’t just ask, “Do you smoke?” Ask, “Are you using any nicotine products? What are you using in your vape?”
Thomas Jordan, MDDr. Jordan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
As medical and recreational marijuana become legalized in more states, more emphasis is being placed on treatment of those with cannabis use disorders. But with our clinics already at capacity, how can we find the most efficient way of providing therapy?
Rehan Aziz, MDDr. Aziz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Type 2 diabetes (T2D) is a common condition with high treatment costs and significant morbidity and mortality. In 2015, an estimated 30.2 million American adults had T2D. Diabetes can be comorbid with other behavioral health disorders (BHDs), and this can lead to additional costs and increased morbidity and mortality risk.